Predictability of vancomycin trough concentrations using seven approaches for estimating pharmacokinetic parameters

Area of Science:

• Pharmacokinetics
• Clinical Pharmacy
• Pharmacometrics

Background:

• Vancomycin is a critical antibiotic for treating serious Gram-positive infections.
• Accurate dosing of vancomycin is essential to achieve therapeutic efficacy and minimize toxicity.
• Therapeutic drug monitoring (TDM) of vancomycin serum concentrations is standard practice.

Purpose of the Study:

• To evaluate seven different methods for estimating vancomycin pharmacokinetic parameters.
• To determine which estimation method best predicts measured vancomycin concentrations in a community teaching hospital patient population.
• To assess the reliability of these methods compared to actual therapeutic drug monitoring.

Main Methods:

• Retrospective review of data from 189 adult patients receiving vancomycin.
• Analysis included patient demographics, vancomycin dosage, and measured trough concentrations.
• Seven distinct methods were used to estimate vancomycin volume of distribution, clearance, and elimination rate constant.

Main Results:

• The coefficients of determination for the seven methods ranged from 0.114 to 0.234.
• The Matzke method demonstrated the best balance of low bias and high precision among the tested methods.
• Prediction accuracy varied, with only 18.0-43.9% of predictions within 2.5 mg/L of measured concentrations.

Conclusions:

• The seven methods for estimating vancomycin pharmacokinetic parameters exhibited significant variability in predicting actual serum concentrations.
• None of the evaluated estimation methods were found to be sufficiently reliable to substitute for therapeutic drug monitoring.
• Clinical decisions regarding vancomycin therapy should continue to be guided by measured serum concentrations.